$24.95
0.140.56%
At close: Nov 11, 4:00 PM EST
$24.95
0.140.56%
Pre-Market: 4:09 AM EST
Collegium Pharmaceutical Inc
COLLNASDAQ
Collegium Pharmaceutical fell 46.5% from $46.38 to $24.81, behind the S&P 500's +12.7%. Its worst day was Aug 6 (−18.6%), and its low came Oct 13 at $21.53.
Nov 13, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Collegium Pharmaceutical closed at its highest level of the year, 7.5% above where the year started.
+0.5% · S&P 500 0.0%
Collegium Pharmaceutical shares fell 6.6%, while the S&P 500 rose 0.7%.
−6.6% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
EPS of $2.04 missed the $2.09 estimate on $205.4M revenue (est. $207.3M); FY revenue guidance of $805.0M–$825.0M against the $806.8M consensus.
−3.3% · S&P 500 −0.6%
EPS of $1.76 beat the $1.46 estimate on $193.5M revenue (est. $183.7M); FY revenue guidance of $805.0M–$825.0M against the $832.5M consensus.
+7.7% · S&P 500 −0.3%
EPS of $1.92 beat the $1.70 estimate on $199.9M revenue (est. $202.3M); FY revenue guidance of $825.0M–$855.0M against the $872.4M consensus.
−18.6%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 −0.2%
Collegium Pharmaceutical closed at its lowest level of the year, 53.6% below where the year started.
−2.4% · S&P 500 0.0%
EPS of $1.96 beat the $1.79 estimate on $216.3M revenue (est. $215.8M); FY revenue guidance of $825.0M–$855.0M against the $832.9M consensus.
+6.3% · S&P 500 −4.4%
Where it ended: a close of $24.81 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $1.88, revenue est. $222.0M).
Nothing in the past 12 months.
All COLL dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for COLL and SPY from Benzinga historical bars. Not investment advice.
